Profile
Full Name
Lucid Diagnostics Inc.Ticker Symbol
LUCDExchange
NASDAQSector
HealthcareIndustry
Medical DevicesCountry
United StatesIPO
October 14, 2021Indexes
Not includedWebsite
http://www.luciddx.comEmployees
72Key Details
Price
$1.17(-6.40%)
Market cap
$106.18M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$4.35M(+79.00% YoY)
Annual EPS
-$1.05(+16.67% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Lucid Diagnostics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 11, 25 Needham
BuyMar 26, 25 Cantor Fitzgerald
OverweightMar 24, 25 Needham
BuyDec 9, 24 Ascendiant Capital
BuyNov 15, 24 Cantor Fitzgerald
OverweightNov 14, 24 Needham
BuyNov 14, 24 Canaccord Genuity
BuySep 10, 24 Ascendiant Capital
BuyAug 13, 24 Needham
BuyAug 13, 24 Canaccord Genuity
BuyInstitutional Ownership
- What is the ticker symbol for Lucid Diagnostics?
- Does Lucid Diagnostics pay dividends?
- What sector is Lucid Diagnostics in?
- What industry is Lucid Diagnostics in?
- What country is Lucid Diagnostics based in?
- When did Lucid Diagnostics go public?
- Is Lucid Diagnostics in the S&P 500?
- Is Lucid Diagnostics in the NASDAQ 100?
- Is Lucid Diagnostics in the Dow Jones?
- When was Lucid Diagnostics's last earnings report?
- When does Lucid Diagnostics report earnings?
- Should I buy Lucid Diagnostics stock now?
What is the ticker symbol for Lucid Diagnostics?
The ticker symbol for Lucid Diagnostics is NASDAQ:LUCD
Does Lucid Diagnostics pay dividends?
No, Lucid Diagnostics does not pay dividends
What sector is Lucid Diagnostics in?
Lucid Diagnostics is in the Healthcare sector
What industry is Lucid Diagnostics in?
Lucid Diagnostics is in the Medical Devices industry
What country is Lucid Diagnostics based in?
Lucid Diagnostics is headquartered in United States
When did Lucid Diagnostics go public?
Lucid Diagnostics's initial public offering (IPO) was on October 14, 2021
Is Lucid Diagnostics in the S&P 500?
No, Lucid Diagnostics is not included in the S&P 500 index
Is Lucid Diagnostics in the NASDAQ 100?
No, Lucid Diagnostics is not included in the NASDAQ 100 index
Is Lucid Diagnostics in the Dow Jones?
No, Lucid Diagnostics is not included in the Dow Jones index
When was Lucid Diagnostics's last earnings report?
Lucid Diagnostics's most recent earnings report was on Mar 24, 2025
When does Lucid Diagnostics report earnings?
The next expected earnings date for Lucid Diagnostics is May 13, 2025
Should I buy Lucid Diagnostics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions